Vector Laboratories, Inc.

Newark, CA

UEI
FGJZH15RUSZ2
CAGE
0KZ86
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
6737 Mowry Ave, Newark, CA 94560, USA
Website
vectorlabs.com
Founded
1976
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 $49,394

Contract awards

Award Agency Obligated Awarded
Manufacture and provision of ricin and ricin a-chain 75D30123P17052 CDC Pittsburgh $49,394
Ricin a chain from vector laboratories 70FA2021F00000041 FEMA Preparedness Section $7,494
Laboratory supplies - biological - anti-ricin i & II antibody 75D30121P11339 CDC Pittsburgh $24,457
Ricin a chain for the CDP 70FA2020F00000053 FEMA Preparedness Section $9,284
Anti-RCA i & II antibody 75D30120P07291 CDC Pittsburgh $23,755

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Vector Laboratories, Inc., doing business as Vector Laboratories Inc., is a manufacturer of goods specializing in the development and commercialization of labeling and detection reagents for various research fields including immunohistochemistry, immunofluorescence, DNA/RNA detection and glycobiology. The company provides products to support public health and infectious disease research.

Through prime federal contract awards, Vector Laboratories has provided ricin, ricin A-chain, anti-ricin antibodies, and other biological reagents to the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) in Pittsburgh and the Federal Emergency Management Agency (FEMA) Preparedness Section. These contracts, ranging in value from $7,493 to $49,394, were firm fixed price purchase orders or BPA calls awarded between 2019 and 2023 to support CDC infectious disease control efforts and FEMA emergency preparedness. No subcontracts or set aside designations were associated with the prime awards to Vector Laboratories.

SBA capabilities narrative

Labeling and Detection Reagents for Protein Detection in Biological Systems

Keywords:

Immunohistochemistry, Immunofluorescence, In Situ Hybridization, DNA/RNA Labeling, Glycobiology and Lectins, Blotting Applications, Neural Tracing, Biotin-(Strept)avidin Systems, Secondary Antibodies, Mounting Media, Fusion Protein Reagents, and Enzyme Substrates

Quick answers

Is Vector Laboratories, Inc. registered in SAM.gov?

Vector Laboratories, Inc.'s SAM.gov registration expired on July 31, 2026.

How much has Vector Laboratories, Inc. received in federal contracts?

Federal contracts obligated $49,394 to Vector Laboratories, Inc. in fiscal years 2023 through 2027.

What is Vector Laboratories, Inc.'s most recent federal award?

Vector Laboratories, Inc.'s most recent federal contract award is Manufacture and provision of ricin and ricin a-chain (75D30123P17052), from CDC Pittsburgh, on July 26, 2023.

On GovTribe

See Vector Laboratories, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors